Sort
82,697 grants matching “vaccine development”
RPCI-UPCI Ovarian Cancer SPORE
$1,750,206Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2018 · CA
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$1,749,896Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2025 · AI
Mayo Clinic Ovarian Cancer SPORE
$1,749,801Scott H Kaufmann · Mayo Clinic Rochester · P50 · FY2022 · CA
Noroviruses and Epidemic Gastroenteritis
$1,749,583Kim Y. Green · National Institute Of Allergy And Infectious Diseases · ZIA · FY2025 · AI
Large Scale T Cell Epitope Discovery:Global identification of epitopes derived from Zika (ZIKV), Chikungunya (CHIKV) viruses following natural infection and vaccination
$1,749,446Maya Mitchell · La Jolla Institute For Immunology · N01 · FY2021 · AI
Integrated CV-N Preclinical Clinical Microbicide Program
$1,748,609Biosyn, Inc. · U19 · FY2002 · AI
Adjuvant Development Program
$1,748,502Nikolai Petrovsky · Vaxine Pty Ltd · N01 · FY2009 · AI
The molecular pathogenesis of varicella zoster virus infection
$1,748,323Donald Gilden · University Of Colorado Denver · P01 · FY2009 · AG
DNA Vaccine for Induction of Mucosal Immunity
$1,748,222David B. Weiner · University Of Pennsylvania · P01 · FY2007 · AI
CoVPN 3008 Multi-Center, Randomized, Efficacy Study of Early vs Deferred Vaccination with COVID-19 mRNA Vaccine in Regions with SARS-CoV-2 Variants of Concern - LC Repository
$1,748,110Margaret Juliana McElrath · Fred Hutchinson Cancer Center · UM1 · FY2023 · AI
University of Arizona Cancer Prevention Clinical Trials Network
$1,747,889Patricia Ann Thompson-Carino · University Of Arizona · UG1 · FY2025 · CA
Plasma Cells in Health and Disease
$1,747,765Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
Regulation of Pathogenic Plasma Cells in Human SLE
$1,747,765Ignacio E. Sanz · Emory University · P01 · FY2020 · AI
The FIOCRUZ Therapeutic and Prevention HIV/AIDS Clinical Trials Unit.
$1,747,343Beatriz Grinsztejn · Fundacao Oswaldo Cruz · UM1 · FY2022 · AI
Evaluation of Optimized Lead Candidates for Encephalitic Alphaviruses in Animal Models
$1,747,217Colleen B Jonsson · University Of Tennessee Health Sci Ctr · U19 · FY2020 · AI
Innate Immune Antivirals for Biodefense
$1,746,712Michael J Gale · University Of Washington · R01 · FY2015 · AI
RP3: Therapeutics Human Monoclonal Antibody Treatments for Filoviruses
$1,746,519James E Crowe · University Of Texas Med Br Galveston · U19 · FY2014 · AI
HIV IMPAACT RELATED STUDIES
$1,746,450Barbara Driver · Westat, Inc. · N01 · FY2020 · HD
Technology and Computational Core
$1,746,108Alexandra-Chloe Villani · Brigham And Women'S Hospital · P01 · FY2021 · AI
Roswell Park Ovarian Cancer SPORE
$1,745,539Kirsten B Moysich · Roswell Park Cancer Institute Corp · P50 · FY2024 · CA
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation
$1,744,691Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2019 · AI
Targeting Immunogenicity to the MPER Hinge and C-helix for BNAb Elicitation
$1,744,691Ellis L Reinherz · Dana-Farber Cancer Inst · P01 · FY2020 · AI
DEVELOPMENT OF SAS A SYNTHETIC AS01-LIKE ADJUVANT SYSTEM FOR INFLUENZA VACCINES
$1,744,408David Burkhart · Inimmune Corporation · N01 · FY2023 · AI
Innate Immune Responses and Vaccines Against Tumor-Associated Herpesviruses
$1,743,351Ren Sun · University Of California Los Angeles · P01 · FY2015 · CA
Human Dendritic Cells and In Vivo Immunity to Biothreat
$1,743,317Baylor Research Institute · U19 · FY2003 · AI